Beststores Smith and Nephew Iodosorb Gel Tube 40G 6602125040

Product Information

Smith + Nephew 2017.Review of Perstorp Pharma Absorption Capacity Quality Assurance Data for IODOSORB Powder. Internal Report. DS/17/363/R.

Use of topical iodine is not recommended for newborn infants because it may cause skin and thyroid problems. Geriatric This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: risks related to the impact of COVID-19, such as the depth and longevity of its impact, government actions and other restrictive measures taken in response, material delays and cancellations of elective procedures, reduced procedure capacity at medical facilities, restricted access for sales representatives to medical facilities, or our ability to execute business continuity plans as a result of COVID-19; economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers (including, without limitation, as a result of COVID-19); price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers (including, without limitation, as a result of COVID-19); competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations. IODOSORB Dressing is a unique topical antimicrobial with dual-action, offering the benefits of a broad-spectrum, sustained-activity antimicrobial agent in combination with desloughing and fluid-handling properties, making it effective against biofilm in vitro and in vivo. 2-28Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 2009;17(3):354-359. Iodine is secreted into breast milk. Clinical experience of use in lactating women is limited. Iodosorb medicated ointment should therefore not be used in lactating women. Smith + Nephew 2017. Review of Perstorp Pharma Absorption Capacity Quality Assurance Data for IODOSORB/IODOFLEX Dressings. Internal Report. DS/17/365/R.

Holloway GA Jr, Johansen KH, Barnes RW, Pierce GE. Multicenter trial of cadexomer iodine to treat venous stasis ulcer. West J Med. 1989;151(1):35-38. Iodosorb Cadoxemer Iodine Ointment reduces bacteria, absorbs exudate, pus and debris, facilitates desloughing and maintains a moist wound environment to promote healing of chronic ulcers and wounds such as venous stasis ulcers, pressure sores, diabetic foot ulcers, and infected traumatic and surgical wounds. IODOSORB ointment is a unique and highly absorbent formulation, helping to manage exudate and disinfect wounds. The ointment is effective at absorbing moisture, which can help to speed up the healing process. IODOSORB ointment is also non-irritating and latex free, making it a safe choice for those with sensitive skin. Benefits of Iodosorb Ointment IODOSORB absorbs exudate and acts as a wound disinfectant Smith + Nephew 2007.An evaluation of the use of IODOSORB ointment and dressing in the management of chronic exuding wounds. Internal Report. SR/CE/027/IOD. Thoroughly clean the wound and surrounding area with a gentle stream of sterile water or saline. Remove excess fluid, leaving wound surface slightly moist.Smith + Nephew 2018.Antimicrobial activity of IODOSORB range against a broad spectrum of wound pathogens. Internal Report. 1801001. Woo K, Dowsett C, Costa B, Ebohon S, Woodmansey EJ, Malone M. Efficacy of topical cadexomer iodine treatment in chronic wounds: Systematic review and meta-analysis of comparative clinical trials. Int Wound J. 2021;[Epub ahead of print]. This medicine can stain your skin and clothing. Alcohol may be used to remove iodine stain on the skin. Stains on clothing can be removed by washing and rinsing them in ammonia diluted with water. Stains on starched linens can be removed by washing them in soap and water. Side Effects of Iodosorb